(Reuters) - Advanced Medical wants to wrest Bausch & Lomb away from its
existing agreement to be acquired by private equity firm
Warburg Pincus for $3.67 billion.
But Advanced Medical's offer has been opposed by its
third-largest shareholder, ValueAct Capital. A lack of support
by a key investor makes Advanced Medical's offer more risky,
analysts have said.
Read more at Reuters.com Government Filings News
existing agreement to be acquired by private equity firm
Warburg Pincus for $3.67 billion.
But Advanced Medical's offer has been opposed by its
third-largest shareholder, ValueAct Capital. A lack of support
by a key investor makes Advanced Medical's offer more risky,
analysts have said.
Read more at Reuters.com Government Filings News
No comments:
Post a Comment